Korean J Ophthalmol.  2016 Aug;30(4):311-312. 10.3341/kjo.2016.30.4.311.

Successful Treatment with Chronic Conjunctivitis: Removal of Tarsoconjunctival Crypt

• Na YH
• Seo SJ
• Shin JY
• Lee JH
• Kim JH
• Lee DH

• KMID: 2373993
• DOI: http://doi.org/10.3341/kjo.2016.30.4.311

Abstract

No abstract available.

MeSH Terms

Adult
Anti-Bacterial Agents/*therapeutic use
Chronic Disease
Conjunctiva/*surgery
Conjunctivitis/drug therapy/*surgery
Female
Follow-Up Studies
Humans
Ophthalmologic Surgical Procedures/*methods
Anti-Bacterial Agents

Figure

• 

  Fig. 1 Photographs showing the everted upper eyelids of a 40-year-old woman with chronic conjunctivitis. (A) Left upper lid, eversion of the left upper eyelid reveals tarsoconjunctival scarring and multiple concretions. (B) Right upper lid, eversion of the right upper lid reveals a pseudomembrane on the medial tarsal conjunctival surface and subconjunctival fibrosis. (C) Right upper lid, a probe is passed through the fistulous opening to expose the full length of the tarsoconjunctival tract. (D) Right upper lid, squeezing of the tarsal plate expels multiple concretions through the exposed crypts. (E) Left upper lid, 1 month after the procedure, conjunctival injection is much improved, and the dense conjunctival fibrosis was decreased but still present. (F) Right upper lid, the same findings as for left tarsoconjunctiva.

Reference

1. Rose GE. The giant fornix syndrome: an unrecognized cause of chronic, relapsing, grossly purulent conjunctivitis. Ophthalmology. 2004; 111:1539–1545.

2. Sotozono C, Ueta M, Nakatani E, et al. Predictive factors associated with acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis. Am J Ophthalmol. 2015; 160:228–237.e2.

3. Tse BC, Shriver EM, Tse DT. Tarsoconjunctival crypts: unrecognized cause of chronic mucopurulent conjunctivitis. Am J Ophthalmol. 2012; 154:527–533.